Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Zlatic

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|December 24, 2024
The value of real world evidence and pragmatic trials in advanced prostate cancer- insights from the electronic Prostate Cancer Australian and Asian DatabaseAngelyn Anton, Kristina Zlatic, Sophie O'Haire, et al.
Blood|September 2, 2004
Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1Kenneth W Harder, Cathy Quilici, Edwina Naik, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapiesCiara Conduit, Bruno Valentin Sinn, Catherine Mitchell, et al.
Asia-Pacific Journal of Clinical Oncology|January 29, 2026
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case SeriesKar Ven Cavan Chow, Ciara Conduit, Sophie O'Haire, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|December 24, 2024
The value of real world evidence and pragmatic trials in advanced prostate cancer- insights from the electronic Prostate Cancer Australian and Asian DatabaseAngelyn Anton, Kristina Zlatic, Sophie O'Haire, et al.
Blood|September 2, 2004
Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1Kenneth W Harder, Cathy Quilici, Edwina Naik, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapiesCiara Conduit, Bruno Valentin Sinn, Catherine Mitchell, et al.
Asia-Pacific Journal of Clinical Oncology|January 29, 2026
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case SeriesKar Ven Cavan Chow, Ciara Conduit, Sophie O'Haire, et al.
Pageof 1